What is the dosage of dabrafenib?

Dabrafenib is a targeted anti-cancer drug mainly used to treat unresectable or metastatic melanoma, metastatic non-small cell lung cancer and locally advanced or metastatic anaplastic thyroid cancer harboring BRAF V600E or V600K mutations. Dabrafenib inhibits tumor growth and spread by specifically inhibiting the activity of BRAF protein and blocking signal transduction in tumor cells.

Regarding the dosage of dabrafenib, according to authoritative medical guidelines and drug instructions, the recommended dosage of dabrafenib for adult patients is 150 mg each time, twice daily. This means patients need to take the drug twice a day, taking one 150 mg capsule each time. To ensure optimal absorption, dabrafenib should be taken at least 1 hour before or 2 hours after a meal, and the two doses should be taken approximately 12 hours apart.

For pediatric patients, the dosage of dabrafenib needs to be adjusted based on body weight. In general, pediatric patients weighing at least 26 kg can be treated with dabrafenib. The specific dosage adjustment plan needs to be formulated by the doctor based on the specific situation of the patient.

It is worth noting that dabrafenib usually needs to be used in combination with other drugs to achieve better therapeutic effects. For example, dabrafenib is often used in combination with the MEK inhibitor trametinib in the treatment of BRAF-mutated melanoma. When used together, the dosage and duration of use of the two drugs must follow the doctor's recommendations and guidance.

In addition, dabrafenib dosage may need to be adjusted in patients with hepatic or renal impairment. Patients with mild hepatic impairment usually do not need to adjust the dosage, but patients with moderate or severe hepatic impairment and patients with severe renal impairment should use this product with caution and adjust the dosage under the guidance of a doctor.

During the period of medication, patients should follow the doctor's instructions and undergo relevant examinations regularly to monitor changes in condition and side effects of the medication. If symptoms of discomfort occur or overdose is suspected, you should seek medical advice promptly and inform your doctor that you are using dabrafenib. At the same time, patients should also pay attention to maintaining a good mentality and living habits to improve treatment effects and quality of life.